EJSW may regulate key ITP targets, and protect vascular integrity through AGE-RAGE signalling, complement and coagulation cascades, and VEGF signalling by downregulating TNF-α, IL-1β and other inflammatory factors. This evidence concerns the gene TNF and autoimmune thrombocytopenic purpura.